Erik Anders Kronström
Chief Operating Officer at INFANT BACTERIAL THERAPEUTICS AB
Net worth: 89 953 $ as of 2024-04-29
Erik Anders Kronström active positions
| Companies | Position | Start | End |
|---|---|---|---|
| INFANT BACTERIAL THERAPEUTICS AB | Chief Operating Officer | 2017-12-31 | - |
| Chief Tech/Sci/R&D Officer | 2014-10-19 | 2017-12-31 |
Career history of Erik Anders Kronström
Former positions of Erik Anders Kronström
| Companies | Position | Start | End |
|---|---|---|---|
Biosergen AS
 Biosergen AS BiotechnologyHealth Technology Biosergen AS develops drugs based on biosynthetic engineering of natural products, combined with chemical synthesis. It develops antibiotics for the use in antifungal therapy. The firm uses engineered biosynthesis technology that allows alterations in microbial genes, which lead to predictable changes in the final structure of the natural product. The company was founded in 2004 and is headquartered in Tiller, Norway. | Chief Executive Officer | - | - |
Training of Erik Anders Kronström
| Warwick Business School | Masters Business Admin |
| Royal Institute of Technology | Graduate Degree |
Statistics
International
| Sweden | 3 |
| United Kingdom | 2 |
| Norway | 2 |
Operational
| Chief Executive Officer | 1 |
| Graduate Degree | 1 |
| Masters Business Admin | 1 |
Sectoral
| Consumer Services | 3 |
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| INFANT BACTERIAL THERAPEUTICS AB | Health Technology |
| Private companies | 1 |
|---|---|
Biosergen AS
Biosergen AS BiotechnologyHealth Technology Biosergen AS develops drugs based on biosynthetic engineering of natural products, combined with chemical synthesis. It develops antibiotics for the use in antifungal therapy. The firm uses engineered biosynthesis technology that allows alterations in microbial genes, which lead to predictable changes in the final structure of the natural product. The company was founded in 2004 and is headquartered in Tiller, Norway. | Health Technology |